- European Investment Bank has granted Evotec SE ( NASDAQ: EVO ) an unsecured loan facility of € 150M to support the company's R&D activities, equity investments and the building of the new J.POD biologics manufacturing facility on Evotec's Campus Curie in Toulouse, France.
- Through this new financing of €150M, the EIB reiterates its supports to Evotec, a company that it already supported in 2017 with a financing of €75M.
- This new agreement is to be signed in Toulouse during a visit of the site on which the new biologics manufacturing facility will be built.
For further details see:
Evotec gets a €150M loan from European Investment Bank